Published: 19 June 2021
Author(s): Marco Vitolo, Jacopo F Imberti, Anna Maisano, Alessandro Albini, Niccolò Bonini, Anna Chiara Valenti, Vincenzo L Malavasi, Marco Proietti, Jeff S Healey, Gregory YH Lip, Giuseppe Boriani
Issue: October 2021

Modern Cardiac Implantable Electronic Devices (CIEDs) allow continuous monitoring of cardiac electrical activity through one or more electrodes. Atrial High Rate Episodes (AHRE) are defined as device detected, asymptomatic, atrial tachy-arrhythmias, which are found in approximately 20–30% of CIED patients after 1 year of average follow-up.1,2 AHRE are associated with an increased risk of thromboembolic (TE) events and clinically overt Atrial Fibrillation (AF) (standard 12-lead ECG recording or a single-lead ECG tracing of ≥ 30 s showing irregular heart rhythm with no P waves), moreover their prevalence is expected to increase with population aging and comorbidities, representing a significant future management challenge.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.